Among brokerages, Nomura has a Buy rating on M&M while CLSA maintains an Outperform call on Britannia Industries as it believes that its growth deceleration is largely a factor of widening options with consumers. Here are the top brokerage calls for today.
Goldman Sachs on M&M | The brokerage maintains a Buy call on M&M with the company being its preferred pick in the PV/CV space.
Nomura on M&M | Nomura has a Buy rating on M&M with EPS estimates for FY21/FY22/FY23 being raised by 14%/ 2%/ 8%.
Credit Suisse on Britannia Industries | The brokerage has a Neutral call on the stock and is of the view that the company is set for a weak H1FY22 on a YoY basis.
CLSA on Britannia Industries | CLSA said that the company's results were marginally below expectations and believes that its growth deceleration is largely a factor of widening options with consumers.
Nomura on Britannia Industries | Nomura has a Buy call on Britannia as volume miss was offset by enduring margin strength.
Morgan Stanley on Britannia Industries | The brokerage house maintains an Overweight call on Britannia after margin drove earnings beat in Q3.
Credit Suisse on Cadila Healthcare | The brokerage firm has an Underperform call on Cadila as guidance for the US business is weak.
CLSA on Cadila Healthcare | CLSA maintains a Buy call on Cadila Healthcare as it expects R&D initiatives to drive long-term growth.
Goldman Sachs on Divi's Laboratories | The brokerage has a Buy rating on the stock as it expects efforts around process & design at molecule & manufacturing level to support gross margin.
Nomura on Gujarat Gas | Nomura has a Buy call on Gujarat Gas as it expects Q4 margin to be robust as well.
Morgan Stanley on Gujarat Gas | The brokerage maintains an Overweight call on Gujarat Gas with a target of Rs 467 per share.
Goldman Sachs on BHEL | The brokerage maintains a Sell call on BHEL as it is of the view that the company's growth visibility remains low.